4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,001 | 90,989 | 243,743 | 259,865 | 276,726 |
| Marketable Securities | 94,776 | 70,686 | N/A | N/A | N/A |
| Receivables | 47 | 791 | 1,218 | 965 | 1,486 |
| TOTAL | $256,280 | $165,733 | $248,752 | $264,501 | $282,656 |
| Non-Current Assets | |||||
| PPE Net | 14,391 | 8,789 | 5,580 | 5,011 | 5,073 |
| Investments And Advances | 67,652 | 65,494 | 0 | 0 | 0 |
| Other Non-Current Assets | 15,164 | 602 | 602 | 602 | 602 |
| TOTAL | $97,207 | $74,885 | $6,182 | $5,613 | $5,675 |
| Total Assets | $353,487 | $240,618 | $254,934 | $270,114 | $288,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,764 | 3,713 | 1,962 | 1,284 | 1,787 |
| Accrued Expenses | 7,744 | 5,932 | 4,892 | 5,545 | 8,371 |
| TOTAL | $16,338 | $11,373 | $9,870 | $13,916 | $16,744 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,599 | 1,728 | 3,016 | 7,087 | 6,586 |
| Other Non-Current Liabilities | 15,551 | 2,101 | 2,076 | 2,077 | 1,974 |
| TOTAL | $18,042 | $5,111 | $4,418 | $13,767 | $15,200 |
| Total Liabilities | $34,380 | $16,484 | $14,288 | $27,683 | $31,944 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,238 | 32,139 | 26,988 | 26,746 | N/A |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -206,996 | -181,913 | -159,674 | -152,085 | -135,679 |
| Other shareholders' equity | -423 | -195 | 0 | 0 | 0 |
| TOTAL | $319,107 | $224,134 | $240,646 | $242,431 | $256,387 |
| Total Liabilities And Equity | $353,487 | $240,618 | $254,934 | $270,114 | $288,331 |